GREEN SHEET REDIGEST
HB 578 2021 Regular Session Amedee
HEALTH CARE: Provides relative to disclosure of certain information relative to
abortion pill reversal.
DIGEST
Present law provides for the regulation of abortions in this state to the extent it is provided
for under federal law.
Proposed law requires a physician or agent acting under the direction of the physician
administers to provide a disclosure statement when administering or dispensing mifepristone
to a pregnant woman by doing any of the following:
(1) Stapling the disclosure statement to a bag, envelope, or other package that contains
misoprostol for the pregnant woman to self-administer at home.
(2) Attaching the disclosure statement to a written prescription for misoprostol provided
by the physician or agent.
(3)Attaching the disclosure statement to the patient's discharge instruction if the
prescription for misoprostol is sent directly to a pharmacy.
Proposed law requires the Louisiana Department of Health to provide the disclosure
statement on an internet webpage.
Proposed law requires the disclosure statement to contain the following text:
ABORTION PILL REVERSAL? PLEASE READ BEFORE TAKING
SECOND PILL: Recent research has indicated that the first pill provided,
identified as mifepristone, is not always effective in ending a pregnancy. You
may be able to avoid, cease, or reverse the intended effects of a chemically-
induced abortion if the second pill provided, identified as misoprostol, is not
taken and a trained medical professional provides an established progesterone
protocol. If you want to discuss the possibility of continuing your pregnancy,
please consult your physician or healthcare provider immediately. Please
visit www.PregnancyInfo.La.gov.
Proposed law shall not be construed to do any of the following:
(1)Create or recognize a right to abortion.
(2)Require the disclosure statement to be provided to a woman facing a spontaneous
miscarriage.
(3)Require a pharmacy or any entity other than the facility where the abortion is
administered to provide the disclosure statement.
Proposed law defines "abortion pill", "mifepristone", and "misoprostol".
Proposed law provides for the severability of proposed law.
Proposed law shall become effective upon the date that an abortion pill reversal regimen or
protocol is approved or authorized by the U.S. Food and Drug Administration or the regimen
or protocol is approved or authorized as a standard of care by the American College of
Obstetrics and Gynecology.
(Adds R.S. 40:1061.11.1)
Page 1 of 2
Prepared by Brandi Cannon. Summary of Amendments Adopted by House
The House Floor Amendments to the engrossed bill:
1. Change language of disclosure statement required by proposed law.
2. Delete the requirement that LDH identify a certain webpage and display its logo
on the webpage.
3. Make technical changes.
Summary of Amendments Adopted by Senate
Committee Amendments Proposed by Senate Committee on Health and Welfare to the
reengrossed bill
1. Provide for the interpretation of proposed law.
2. Provide for an effective date.
3. Make technical changes.
Page 2 of 2
Prepared by Brandi Cannon.